Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )
First received: May 12, 2011
Last updated: March 10, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||July 2016|
|Primary Completion Date:||October 2014 (Final data collection date for primary outcome measure)|